ACACA and autoimmune disease: Inhibiting lipid metabolic protein ACC1 (acetyl-CoA carboxylase 1) in vivo dysregulates the formation of Th17 CD4 T cells, promotes Treg cell development, and prevents the Th17-mediated autoimmune disease experimental autoimmune encephalomyelitis.6